|
|
|
|
|
News and Articles on Macroglobulinemia
Common Blood Disorder May Not Be Linked To As Many Serious Diseases Aug 27, 2009
27, 2009) A symptomless blood disorder, monoclonal gammopathy of undetermined significance, known as MGUS, is not linked to as many serious diseases as previously thought. This finding may save patients from undergoing unnecessary workup and treatment according to a study published in the August 2009 issue of Mayo Clinic Proceedings. (Science Daily)
Mayo Clinic Proceedings: Common blood disorder may not be linked to as many serious diseases Aug 26, 2009
MGUS has long been thought to be a precursor of serious disease, such as multiple myeloma, primary amyloidosis and Waldenstrm macroglobulinemia. However, for years physicians have reported possible association of MGUS with many more diseases. (EurekAlert!)
Proteolix Presents Phase 1b/2 Clinical Data for Carfilzomib in Advanced Solid Tumor Patients at the 2009 ASCO Annual Meeting May 31, 2009
In Phase 1 and Phase 2 clinical trials, carfilzomib has demonstrated single-agent activity in hematologic malignancies and solid tumors, including multiple myeloma, Waldenstrom's macroglobulinemia, mantle cell lymphoma, and renal cell carcinoma. Proteolix is conducting a comprehensive clinical development program evaluating carfilzomib for the treatment of multiple myeloma, including an ongoing accelerated approval study in heavily pre-treated relapsed/refractory patients and a Phase 2 clinical... (PR Newswire)
[ Terms Of Use | Privacy | About ]
©1998-2009 SurfWax, Inc.
All rights reserved. Patents pending.
|
|
|
Copyright SurfWax, Inc. 2009
|
|
